The largest database of trusted experimental protocols

Anti α smooth muscle actin α sma

Manufactured by Merck Group
Sourced in United States, Japan

Anti-α-smooth muscle actin (α-SMA) is a laboratory product used to detect the presence of α-smooth muscle actin, a protein found in smooth muscle cells. It is commonly used in research applications to identify and quantify smooth muscle cells in various tissue samples.

Automatically generated - may contain errors

16 protocols using anti α smooth muscle actin α sma

1

Quantifying Pulmonary Arterial Remodeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Left upper lung tissues were fixed with 4% paraformaldehyde, paraffin-embedded, and sliced with 4 µm thickness. Lung tissue sections were stained with hematoxylin and eosin (H&E). To determine the extent of collagen deposition in pulmonary arteries, Sirius red staining and Masson trichrome staining was performed and quantified by modified ashcroft scoring system [15 (link)16 (link)]. For immunohistochemisty, the tissue sections were blocked with peroxidase blocking agent for 5 min, washed with Tris-HCl with Tween (TBST), and blocked with protein blocking serum free buffer for 5 min. Then, sections were incubated with anti-α-smooth muscle actin (α-SMA) (Sigma-Aldrich Co.) or anti-von Willebrand Factor (vWF) (Millipore, Temecula, CA) overnight at 4℃ followed by washing with TBST for 5 min. Enough labelled polymer conjugated with secondary antibodies (Dako, Carpinteria, CA) were applied to the slides for 30 min, followed by washing with TBST for 5 min. Peroxidase activity was detected with the ready-to-use AEC+substrate chromogen (Dako). At least twenty arteries of 15-100 µm per each rat were evaluated in α-SMA stained slides through a light microscope (imager M1, Carl Zeiss, Jena, Germany) at ×400 magnification and quantified by image J software.
The medial wall thickness is calculated as follows:
Wall thickness=(total area of artery–lumen area of artery)/total area of artery
+ Open protocol
+ Expand
2

Quantifying Cardiac Capillary and Arteriole Density

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart sections (10 μm) were incubated with primary antibodies. Capillary was labelled with fluorescein-labelled Griffonia Bandeiraea simplicifolia isolectin B4 (IB4, 1:50; Molecular Probe, Invitrogen, USA) or vWF and arteriole was stained by anti-α-smooth muscle actin (α-SMA; 1:100; Sigma-Aldrich). The number of capillary and arteriole was counted using image-analysis software (Image J, NIH) and expressed as capillary density per field [10 (link),12 (link),13 (link),18 (link),19 (link)].
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Vascular and Neuronal Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described in detail previously [20 (link)], samples were fixed in 4% paraformaldehyde and blocked with normal goat serum. For smooth muscle and the endothelial content staining, anti-α smooth muscle actin (αSMA) (1:400; Sigma Aldrich Co.), anti-endothelial nitric oxide synthase (eNOS) (1:100; Becton, Dickinson and Company, Franklin Lakes, NJ, USA), and anti-von Willebrand factor (vWF) (1:400; Abcam, Cambridge, UK) were used. For neuronal staining, anti-neuronal nitricoxide synthase (nNOS) (1:100; Novus Biologicals, Centennial, CO, USA) was used. The nucleus was stained using 4,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA, USA). Goat anti-mouse and goat anti-rabbit (1:400; Thermo Fisher Scientific) were used as secondary antibodies.
+ Open protocol
+ Expand
4

HMGB1 Induces α-SMA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured on cover-slips then treated with different concentrations of HMGB1 for 24 h or 16h. Cells were fixed with 4% paraformaldehyde and stained with anti-α-smooth muscle actin (α-SMA, Sigma) and DAPI for nucleus staining (Calbiochem, San Diego, CA, USA). Cells were then incubated with a secondary antibody, Alexa Fluor 488–conjugated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, Inc., Amish, PA, USA)[24 ]. α-SMA expression was observed using a fluorescence microscope (Zeiss, Carl Zeiss, Göttingen, Germany). The quantification of fluorescence intensity was performed by using Image J software.
+ Open protocol
+ Expand
5

In-vivo α-Klotho Protein Therapy for AKI and CKD

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: anti-α-actinin (Sigma-Aldrich, St. Louis, MO), anti-β-actin (Sigma-Aldrich), anti-Erk and anti-phospho-Erk (Cell Signaling Technology Inc., Danvers, MA), anti-α-Klotho Kl1 (KM2076) (Trans Genic Inc., Kobe, japan), and anti-α-smooth muscle actin (α-SMA) (Sigma-Aldrich). Wheat germ agglutinin (Molecular Probes Inc., Eugene, OR) was used to highlight the cardiac myocyte silhouettes. Secondary antibodies coupled to horseradish peroxidase for immunoblotting, or to FITC and Alexa Fluor for immunohistochemistry, were purchased from Molecular Probes/Invitrogen (Molecular Probes Inc.).
Soluble α-Klotho protein containing the ectodomain of mouse α-Klotho (amino acid number 31–982) with V5 and 6xHis tags at the C-terminus was generated as described previously.2 (link) In the AKI model, α-Klotho protein in phosphate-buffered saline (0.01 mg/kg body weight/day) was injected i.p. for 4 consecutive days starting 24 hours after AKI induction. The same volume of phosphate-buffered saline served as control. In the CKD model, α-Klotho protein (0.3 mg/kg body weight/month) was administered i.p. using osmotic minipumps with phosphate-buffered saline as control (1004, Alzet Durect Corp., Cupertino, CA). Minipumps were replaced monthly, resulting in a total of 3 pumps per animal.
+ Open protocol
+ Expand
6

Immunofluorescence Analysis of Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell monolayers on glass coverslips, were fixed with 4% paraformaldehyde (PFA) and washed with PBS. Fixed cells were permeabilized with 0.3% Triton X–100 (Sigma, Dorset, UK) and incubated with anti‐α‐smooth muscle actin (α‐SMA; 1:100; Sigma), anti‐vimentin (1:900) or anti‐CD31 (1:900) (Abcam, Cambridge, UK) overnight at 4°C. After washing, cells were incubated with Alexa Fluor® 488 donkey‐anti‐rabbit antibody or Alexa Fluor® 594 goat‐anti‐mouse antibody (1:250; ThermoFisher Scientific, Northumberland, UK) for 1 hr in the dark. Glass coverslips were mounted onto slides with Prolong Gold Anti‐Fade Reagent contained DAPI (Life Technologies). Fluorescence signal was detected under a Leica DMRB fluorescence microscope (Leica Biosystems, Milton Keynes, UK). Control sections were incubated with non‐immune mouse or/and rabbit IgG (Sigma) (2 μg IgG/ml) in place of the primary antibody.
+ Open protocol
+ Expand
7

DMEM Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s Modified Eagle’s Medium (DMEM) was purchased from Wako (Osaka, Japan) and FCS from Sigma-Aldrich (St. Louis, MO, USA). Novartis Pharma AG (Basel, Switzerland) provided GLY and IND. CCh was from Sigma-Aldrich and TGF-β1 from R&D Systems (Minneapolis, MN, USA). ERK5 inhibitor, BIX02189, and activin receptor–like kinase 5 (ALK5) inhibitor, SB431542, were from Selleckchem (Houston, TX, USA) and ERK1/2 inhibitor, PD98059, from Calbiochem (La Jolla, CA, USA). Rho-associated coiled-coil forming kinase/Rho binding kinase inhibitor, Y-27632, was from Wako. The primary antibodies were anti-ERK5 (Cell Signaling Technology, Danvers, MA, USA: Catalogue no. #3372), anti–α-smooth muscle actin (α-SMA) (Sigma-Aldrich: Catalogue no. A2547), and anti- ChAT antibody (Merck KGaA, Darmstadt, Germany: Catalogue no. AB144P).
+ Open protocol
+ Expand
8

Western Blot Analysis of Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts were run on 10–12% SDS acrylamide gels and transferred onto nitrocellulose as previously described [19 (link)–21 (link)]. Blots were incubated with anti-caspase-3, anti-PARP, anti-phospho-Erk, anti-phospho(S536)-p65, anti-phospho(S473)-Akt (all Cell Signaling Technology, Beverly, MA), anti-IκBα, anti-phospho(S63)-c-Jun (both Santa Cruz Biotechnology, Santa Cruz, CA), anti-α-smooth muscle actin (αSMA, Sigma-Aldrich, St. Louis, MO) overnight at 4°C. After incubation with secondary horseradish-peroxidase conjugated antibodies (Santa Cruz Biotechnology), the bands were visualized by the enhanced chemiluminescence light method (Amersham Biosciences) and exposed to X-omat film (Eastman Kodak Co., New Haven, CT) or a chemiluminescence imager (Image Station 2000R, Eastman Kodak Co.). Blots were reprobed with monoclonal anti-actin (MP Biomedicals) or GAPDH (Cell Signaling Technology) to demonstrate equal loading.
+ Open protocol
+ Expand
9

Therapeutic Compound Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testosterone propionate, estradiol benzoate and olive oil were purchased from Aladdin Co., Ltd. (Shanghai, China). NAF (>99%) and HJZ-12 (>95%) were synthesized in according with the previous methods (Huang et al., 2015 (link)). Pierce BCA Protein Assay Kit was purchased from Thermo Fisher Scientific (Waltham, MA, United States). Anti-α-smooth muscle actin (α-SMA, 1/400) was purchased from Sigma-Aldrich (MO, United States). Anti-β-actin antibody (1/5000), Bcl-3 polyclonal antibody (1/500) and RRS1 polyclonal antibody (1/500) were purchased from Bioworld Technology (Inc., United States). Rabbit monoclonal anti-proliferating cell nuclear antigen (PCNA, 1/1000), and anti-FGFR3 antibody (1/1000) were purchased from Abcam (Cambridge, MA, United States). Anti-Bmi-1 antibody (1/1000) and anti-cleaved caspase 3 (1/1000) were purchased from Cell Signaling Technology (Beverly, MA, United States). All reagents were prepared fresh before use.
+ Open protocol
+ Expand
10

Quantifying Vessel Formation from SVF Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 2 weeks of expansion, SVF-derived cells were seeded at 1 × 105 cells/cm2 in a flask coated with a solution of 0.1% (v/v) gelatin. At day 10, cells were fixed, permeabilized with 0.1% (v/v) triton X100 (Sigma) and incubated with the antibodies anti-CD31 (ref: JC70A, Dako; Santa Clara, CA, USA) and/or anti-α-smooth muscle actin (α-SMA; ref: 202M-9, Sigma) to evaluate the formation of vessels. 4′,6-diamidino-2-phenylindole (DAPI, Sigma) was used to stain nuclei. Cells were observed under a Nikon Eclipse TE2000-S confocal microscope (Nikon; Champigny sur Marne, France). Quantification of vessel length and the number of vessels involved the use of the FilamentTracer module of Imaris software (Bitplane; Zurich, Switzerland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!